Jefferies Group’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $25.7M | Buy |
298,177
+204,680
| +219% | +$18.3M | 0.21% | 71 |
|
|
2022
Q2 | $8.52M | Sell |
93,497
-52,677
| -36% | -$4.67M | 0.07% | 229 |
|
|
2022
Q1 | $12M | Buy |
146,174
+32,597
| +29% | +$2.57M | 0.08% | 206 |
|
|
2021
Q4 | $8.7M | Sell |
113,577
-62,423
| -35% | -$4.97M | 0.05% | 312 |
|
|
2021
Q3 | $13.2M | Buy |
176,000
+98,371
| +127% | +$7.48M | 0.1% | 194 |
|
|
2021
Q2 | $6.04M | Buy |
77,629
+38,900
| +100% | +$2.89M | 0.04% | 411 |
|
|
2021
Q1 | $2.85M | Buy |
38,729
+24,720
| +176% | +$1.82M | 0.03% | 565 |
|
|
2020
Q4 | $1.09M | Buy |
14,009
+10,828
| +340% | +$828K | 0.01% | 916 |
|
|
2020
Q3 | $252K | Sell |
3,181
-17,465
| -85% | -$1.37M | ﹤0.01% | 1140 |
|
|
2020
Q2 | $1.52K | Buy |
20,646
+1,229
| +6% | +$92.5K | 0.02% | 653 |
|
|
2020
Q1 | $1.43M | Sell |
19,417
-54,985
| -74% | -$4.32M | 0.02% | 841 |
|
|
2019
Q4 | $6.46M | Sell |
74,402
-39,094
| -34% | -$3.21M | 0.05% | 404 |
|
|
2019
Q3 | $9.12M | Buy |
113,496
+40,887
| +56% | +$3.28M | 0.07% | 259 |
|
|
2019
Q2 | $5.81M | Buy |
72,609
+30,064
| +71% | +$2.3M | 0.04% | 401 |
|
|
2019
Q1 | $3.38M | Sell |
42,545
-19,001
| -31% | -$1.42M | 0.03% | 613 |
|
|
2018
Q4 | $4.49M | Sell |
61,546
-80,713
| -57% | -$5.7M | 0.04% | 468 |
|
|
2018
Q3 | $9.63M | Buy |
142,259
+77,109
| +118% | +$4.91M | 0.06% | 290 |
|
|
2018
Q2 | $3.77M | Sell |
65,150
-31,110
| -32% | -$1.76M | 0.02% | 614 |
|
|
2018
Q1 | $5M | Sell |
96,260
-57,964
| -38% | -$3.13M | 0.03% | 467 |
|
|
2017
Q4 | $8.28M | Sell |
154,224
-567,535
| -79% | -$31.5M | 0.04% | 363 |
|
|
2017
Q3 | $44.1M | Buy |
721,759
+439,326
| +156% | +$26.6M | 0.29% | 44 |
|
|
2017
Q2 | $17.3M | Buy |
282,433
+53,030
| +23% | +$3.23M | 0.12% | 156 |
|
|
2017
Q1 | $13.9M | Sell |
229,403
-114,661
| -33% | -$6.96M | 0.1% | 180 |
|
|
2016
Q4 | $19.3M | Buy |
344,064
+324,549
| +1,663% | +$19M | 0.11% | 169 |
|
|
2016
Q3 | $1.16M | Buy |
19,515
+16,358
| +518% | +$957K | 0.01% | 1212 |
|
|
2016
Q2 | $174K | Sell |
3,157
-9,920
| -76% | -$528K | ﹤0.01% | 1850 |
|
|
2016
Q1 | $660K | Buy |
13,077
+7,327
| +127% | +$359K | ﹤0.01% | 1319 |
|
|
2015
Q4 | $290K | Sell |
5,750
-153,127
| -96% | -$7.72M | ﹤0.01% | 1797 |
|
|
2015
Q3 | $7.49M | Buy |
158,877
+51,173
| +48% | +$2.72M | 0.04% | 335 |
|
|
2015
Q2 | $5.85M | Buy |
107,704
+431
| +0.4% | +$24.2K | 0.03% | 456 |
|
|
2015
Q1 | $5.88M | Buy |
107,273
+95,475
| +809% | +$5.41M | 0.03% | 376 |
|
|
2014
Q4 | $639K | Buy |
11,798
+10,355
| +718% | +$577K | ﹤0.01% | 1172 |
|
|
2014
Q3 | $82K | Sell |
1,443
-57,325
| -98% | -$3.22M | ﹤0.01% | 1937 |
|
|
2014
Q2 | $3.24M | Buy |
58,768
+47,918
| +442% | +$2.61M | 0.03% | 463 |
|
|
2014
Q1 | $588K | Buy |
10,850
+6,744
| +164% | +$349K | 0.01% | 1186 |
|
|
2013
Q4 | $196K | Sell |
4,106
-125
| -3% | -$5.71K | ﹤0.01% | 1606 |
|
|
2013
Q3 | $192K | Sell |
4,231
-17
| -0.4% | -$776 | ﹤0.01% | 1626 |
|
|
2013
Q2 | $188K | Buy |
+4,248
| New | +$190K | ﹤0.01% | 1537 |
|
Other funds holding MRK
Jefferies Group's MRK Position: Q3 2022 in Review
Jefferies Group increased its Merck (MRK) stake by 219% in Q3 2022, buying an estimated $18.3M and bringing the position to 298,177 shares worth $25.7M. The position accounts for 0.21% of the portfolio, ranked #71.
Jefferies Group first reported a position in MRK in Q2 2013 and has held it in 38 quarters since. The position peaked at $44.1M in Q3 2017. 2,989 funds tracked by Wall St. Rank hold MRK as of Q3 2022.
- Jefferies Group held 298,177 shares of Merck worth $25.7M as of Q3 2022.
- Jefferies Group bought 204,680 Merck shares in Q3 2022, an estimated $18.3M.
- Merck made up 0.21% of Jefferies Group's portfolio in Q3 2022, its #71 holding.
- Jefferies Group first reported a position in Merck in Q2 2013 and has held it in 38 quarters since.
- Jefferies Group's Merck position peaked at $44.1M in Q3 2017.
- 2,989 funds tracked by Wall St. Rank held Merck as of Q3 2022.
Based on Jefferies Group's 13F filing for Q3 2022, filed 14 Nov 2022.